| Host: |
Mouse |
| Applications: |
ELISA |
| Reactivity: |
C.trachomatis |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Mouse monoclonal antibody anti-Chlamydia trachomatis is suitable for use in ELISA research applications. |
| Clonality: |
Monoclonal |
| Clone ID: |
6703 |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG2a |
| Formulation: |
37 mM citrate, 125 mM phosphate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Purification: |
Purity accurate to greater than or equal to 95% |
| Concentration: |
5.0 mg/ml (+/-10 %) |
| Storage Instruction: |
36 months from manufacturing at 2°C. Temperature analysis:-70 °C, 21 days N/D-20 °C, 21 days OK +4 °C, 21 days OK +30 °C, 21 OK +35 °C, 21 days OK +45 °C, 7 days OK. Shelf life stability testing at 2–8 °C in the product buffer. |
| Association Rate Constant: |
8.9 x 105 1/Ms |
| Determination Method: |
SPR analysis (ProteOn XPR36) |
| Immunoreactivity: |
80–120 % compared to the reference sample in an FIA test |
| Immunogen: |
Chlamydia trachomatis LPS |
| Background | C. trachomatis is a obligate intracellular pathogen and can cause numerous disease states in both men and women. Both sexes can display urethritis, proctitis, trachoma, and infertility. The bacterium can cause prostatitis and epididymitis in men. In women, cervicitis, pelvic inflammatory disease (PID) , ectopic pregnancy, and acute or chronic pelvic pain are frequent complications. C. trachomatis is also an important neonatal pathogen, where it can lead to infections of the eye (trachoma) and pulmonary complications. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
